Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A.I. Clearing Treatment with 0.1% adapalene vs 0.1% adapalene in mild to moderate acne vulgaris
TCTR20171031005Phase 3Not yet recruiting
- Sponsor
- Beiersdorf AG
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of adapalene in acne vulgaris, sponsored by Beiersdorf AG. Planned start Nov 2017; status: not yet recruiting.
02
Drugs
adapalene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on TCTR20171031005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20171031005.